MedKoo Cat#: 597365 | Name: (R)-(-)-Ibuprofen
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

(R)-(-)-Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID); activity resides primarily in the (S)-isomer.

Chemical Structure

(R)-(-)-Ibuprofen
(R)-(-)-Ibuprofen
CAS#51146-57-7 (R-)

Theoretical Analysis

MedKoo Cat#: 597365

Name: (R)-(-)-Ibuprofen

CAS#: 51146-57-7 (R-)

Chemical Formula: C13H18O2

Exact Mass: 206.1307

Molecular Weight: 206.29

Elemental Analysis: C, 75.69; H, 8.80; O, 15.51

Price and Availability

Size Price Availability Quantity
250mg USD 250.00 2 Weeks
500mg USD 400.00 2 Weeks
1g USD 650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
51146-56-6 (S-) 51146-57-7 (R-) 1113403-10-4 (S- lysine) 141505-32-0 (S- lysine hydrate)
Synonym
l-Ibuprofen; Levibuprofen; (R)-(-)-Ibuprofen; (R)-Ibuprofen;
IUPAC/Chemical Name
(R)-2-(4-isobutylphenyl)propanoic acid
InChi Key
HEFNNWSXXWATRW-SNVBAGLBSA-N
InChi Code
InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m1/s1
SMILES Code
O=C(O)[C@H](C)C1=CC=C(CC(C)C)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Biological target:
(R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, inactive on COX, inhibits NF-κB activation; (R)-(-)-Ibuprofen exhibits anti-inflammatory and antinociceptive effects.
In vitro activity:
NF-kB activation was significantly reduced by treatment of Jurkat T cells with 1 mM R(7)-ibuprofen, whereas 10 mM completely prevented NF-kB induction (Figure 1a, lanes 3, 4). The NF-kB-mediated transactivation was suppressed by R(7)-ibuprofen as well as the S(+)-enantiomer in a dose-dependent manner (Figure 1b). Reference: Br J Pharmacol. 1998 Feb;123(4):645-52. https://pubmed.ncbi.nlm.nih.gov/9517383/
In vivo activity:
Measurement of intracellular coenzyme-A levels in isolated rat hepatocytes revealed that R-ibuprofen transiently reduced coenzyme-A levels, whereas S-ibuprofen had no effect. Reference: J Clin Pharmacol. 1996 Dec;36(12 Suppl):27S-32S. https://pubmed.ncbi.nlm.nih.gov/9013381/
Solvent mg/mL mM
Solubility
DMF 45.0 218.14
DMSO 63.7 308.63
Ethanol 50.5 244.81
PBS (pH 7.2) 2.0 9.70
Water 20.8 101.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 206.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Kaehler S, Marsik C, Heinisch B, Thallinger C, Sauermann R, Kazemi-Shirazi L, Wagner O, Joukhadar C. S-ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood. Pharmacology. 2008;81(2):181-6. doi: 10.1159/000111759. Epub 2007 Nov 28. PMID: 18043009. 2. Scheuren N, Bang H, Münster T, Brune K, Pahl A. Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen. Br J Pharmacol. 1998 Feb;123(4):645-52. doi: 10.1038/sj.bjp.0701652. PMID: 9517383; PMCID: PMC1565210. 3. Yoshida H, Kohno Y, Endo H, Yamaguchi J, Fukushima K, Suwa T, Hayashi M. Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats. Biochem Pharmacol. 1997 Jan 24;53(2):179-87. doi: 10.1016/s0006-2952(96)00658-2. PMID: 9037250. 4. Mayer JM. Ibuprofen enantiomers and lipid metabolism. J Clin Pharmacol. 1996 Dec;36(12 Suppl):27S-32S. PMID: 9013381.
In vitro protocol:
1. Kaehler S, Marsik C, Heinisch B, Thallinger C, Sauermann R, Kazemi-Shirazi L, Wagner O, Joukhadar C. S-ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood. Pharmacology. 2008;81(2):181-6. doi: 10.1159/000111759. Epub 2007 Nov 28. PMID: 18043009. 2. Scheuren N, Bang H, Münster T, Brune K, Pahl A. Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen. Br J Pharmacol. 1998 Feb;123(4):645-52. doi: 10.1038/sj.bjp.0701652. PMID: 9517383; PMCID: PMC1565210.
In vivo protocol:
1. Yoshida H, Kohno Y, Endo H, Yamaguchi J, Fukushima K, Suwa T, Hayashi M. Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats. Biochem Pharmacol. 1997 Jan 24;53(2):179-87. doi: 10.1016/s0006-2952(96)00658-2. PMID: 9037250. 2. Mayer JM. Ibuprofen enantiomers and lipid metabolism. J Clin Pharmacol. 1996 Dec;36(12 Suppl):27S-32S. PMID: 9013381.
1: Prud'homme SM, Chaumot A, Cassar E, David JP, Reynaud S. Impact of micropollutants on the life-history traits of the mosquito Aedes aegypti: On the relevance of transgenerational studies. Environ Pollut. 2017 Jan;220(Pt A):242-254. doi: 10.1016/j.envpol.2016.09.056. Epub 2016 Sep 22. PubMed PMID: 27667679. 2: Ji K, Liu X, Lee S, Kang S, Kho Y, Giesy JP, Choi K. Effects of non-steroidal anti-inflammatory drugs on hormones and genes of the hypothalamic-pituitary-gonad axis, and reproduction of zebrafish. J Hazard Mater. 2013 Jun 15;254-255:242-51. doi: 10.1016/j.jhazmat.2013.03.036. Epub 2013 Mar 22. PubMed PMID: 23611805. 3: Bhandari K, Venables B. Ibuprofen bioconcentration and prostaglandin E2 levels in the bluntnose minnow Pimephales notatus. Comp Biochem Physiol C Toxicol Pharmacol. 2011 Mar;153(2):251-7. doi: 10.1016/j.cbpc.2010.11.004. Epub 2010 Nov 24. PubMed PMID: 21111061. 4: Han S, Choi K, Kim J, Ji K, Kim S, Ahn B, Yun J, Choi K, Khim JS, Zhang X, Giesy JP. Endocrine disruption and consequences of chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes) and freshwater cladocerans Daphnia magna and Moina macrocopa. Aquat Toxicol. 2010 Jul 1;98(3):256-64. doi: 10.1016/j.aquatox.2010.02.013. Epub 2010 Feb 20. PubMed PMID: 20236711. 5: Li Y, Lu J. Direct chemiluminescence determination of ibuprofen by the enhancement of the KMnO(4)-sulphite reaction. Luminescence. 2007 Jul-Aug;22(4):326-30. PubMed PMID: 17471464. 6: Luo J, Zhu H, Li H. [Study on characteristics of bias caused by flow injection-capillary electrophoresis with split-flow electrokinetic injection]. Se Pu. 2005 Mar;23(2):189-92. Chinese. PubMed PMID: 16013567. 7: Wang X, Loutzenhiser R. Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF. Am J Physiol Renal Physiol. 2002 Jan;282(1):F124-32. Epub 2003 Mar 11. PubMed PMID: 11739120. 8: Chen H, Huang D, Chen Q, Li H. [Rapid determination of active constituents in compound ibuprofen tablets by capillary zone electrophoresis]. Se Pu. 1998 Jul;16(4):289-92. Chinese. PubMed PMID: 11367761. 9: Borgs M, Bollen M, Keppens S, Yap SH, Stalmans W, Vanstapel F. Modulation of basal hepatic glycogenolysis by nitric oxide. Hepatology. 1996 Jun;23(6):1564-71. PubMed PMID: 8675178. 10: Bhattacharyya DK, Lecomte M, Rieke CJ, Garavito M, Smith WL. Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J Biol Chem. 1996 Jan 26;271(4):2179-84. PubMed PMID: 8567676. 11: Morrison AD. Effect of inhibition of polyol pathway activity on aortic smooth muscle metabolism. Clin Invest Med. 1990 Jun;13(3):119-22. PubMed PMID: 2114245.